Intelligence Platform
Patents
Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7452873
Inhibitors of GSK-3 and uses thereof
granted patentUS 7446199
Compositions useful as inhibitors of protein kinases
granted patentUS 7446112
Modulators of muscarinic receptors
granted patentUS 7442790
Caspase inhibitors and uses thereof
granted patentUS 7442718
Inhibitors of aspartyl protease
granted patentUS 7439249
Inhibitors of phosphatases
granted patentUS 7432292
Sulfhydantoins as phosphate isosteres
granted patentUS 7432290
Inhibitors of IMPDH enzyme
granted patentUS 7427681
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 7423049
Inhibitors of p38
granted patentUS 7419967
Sulfonamide inhibitors of aspartyl protease
granted patentUS 7417029
Prodrug of an ice inhibitor
granted patentUS 7414046
Gyrase inhibitors and uses thereof
granted patentUS 7410956
Caspase inhibitor prodrugs
granted patentUS 7407976
Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
granted patentUS 7407964
Caspase inhibitors and uses thereof
granted patentUS 7407962
Heteroaryl compounds useful as inhibitors or protein kinases
granted patentUS 7390815
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 7390808
Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes
granted patentUS 7388017
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
granted patentUS 7381827
Processes and intermediates
granted patentUS 7378422
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 7371372
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection
granted patentUS 7365092
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted